Business Description
![Cellectis SA Cellectis SA logo](https://static.gurufocus.com/logos/0C000039G0.png?14)
Cellectis SA
ISIN : US15117K1034
Share Class Description:
FRA:ZVAA: ADRCompare
Compare
Traded in other countries / regions
ALCLS.FranceCLLS.USAZVAA.Germany0WA2.UK IPO Date
2015-03-31Description
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.58 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.04 | |||||
Debt-to-EBITDA | -1.61 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.5 | |||||
Beneish M-Score | 0.35 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -77 | |||||
3-Year EBITDA Growth Rate | -21.1 | |||||
3-Year EPS without NRI Growth Rate | -44.9 | |||||
3-Year FCF Growth Rate | 44.4 | |||||
3-Year Book Growth Rate | -41.7 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.87 | |||||
9-Day RSI | 26.39 | |||||
14-Day RSI | 26.33 | |||||
6-1 Month Momentum % | -9.02 | |||||
12-1 Month Momentum % | 35.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 0.94 | |||||
Days Sales Outstanding | 263.25 | |||||
Days Payable | 17574.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.8 | |||||
Shareholder Yield % | -22.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.1 | |||||
Operating Margin % | -1848.65 | |||||
Net Margin % | -1273.67 | |||||
FCF Margin % | -415.01 | |||||
ROE % | -70.52 | |||||
ROA % | -23.67 | |||||
ROIC % | -54.73 | |||||
ROC (Joel Greenblatt) % | -79.48 | |||||
ROCE % | -41.8 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 36.28 | |||||
PB Ratio | 1.57 | |||||
Price-to-Tangible-Book | 1.58 | |||||
EV-to-EBIT | -1.84 | |||||
EV-to-EBITDA | -2.42 | |||||
EV-to-Revenue | 27.54 | |||||
EV-to-Forward-Revenue | 12.04 | |||||
EV-to-FCF | -6.64 | |||||
Earnings Yield (Greenblatt) % | -54.35 | |||||
FCF Yield % | -10.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellectis SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4.736 | ||
EPS (TTM) (€) | -1.245 | ||
Beta | 3.54 | ||
Volatility % | 218.53 | ||
14-Day RSI | 26.33 | ||
14-Day ATR (€) | 0.054488 | ||
20-Day SMA (€) | 1.949 | ||
12-1 Month Momentum % | 35.96 | ||
52-Week Range (€) | 0.905 - 3.22 | ||
Shares Outstanding (Mil) | 100.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cellectis SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cellectis SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cellectis SA Frequently Asked Questions
What is Cellectis SA(FRA:ZVAA)'s stock price today?
The current price of FRA:ZVAA is €1.79. The 52 week high of FRA:ZVAA is €3.22 and 52 week low is €0.91.
When is next earnings date of Cellectis SA(FRA:ZVAA)?
The next earnings date of Cellectis SA(FRA:ZVAA) is 2024-08-02 Est..
Does Cellectis SA(FRA:ZVAA) pay dividends? If so, how much?
Cellectis SA(FRA:ZVAA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |